Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Okam MM et al. | Comparative rates of adverse events with different formulations of intravenous iron. | 2012 | Am. J. Hematol. | pmid:22965928 |
| Derman R et al. | A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. | 2017 | Am. J. Hematol. | pmid:28052413 |
| Suzuki A et al. | Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide. | 1993 | Am. J. Hematol. | pmid:8317471 |
| Hetzel D et al. | A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. | 2014 | Am. J. Hematol. | pmid:24639149 |
| Macdougall IC and Roche A | Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. | 2005 | Am. J. Kidney Dis. | pmid:16112047 |
| Chandler G et al. | Intravenous iron sucrose: establishing a safe dose. | 2001 | Am. J. Kidney Dis. | pmid:11684551 |
| Zager RA et al. | Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. | 2002 | Am. J. Kidney Dis. | pmid:12087566 |
| Oldham FB | Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? | 2002 | Am. J. Kidney Dis. | pmid:12407662 |
| St Peter WL et al. | Trends in intravenous iron use among dialysis patients in the United States (1994-2002). | 2005 | Am. J. Kidney Dis. | pmid:16183420 |
| Folkert VW et al. | Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. | 2003 | Am. J. Kidney Dis. | pmid:12612989 |
| Yee J and Besarab A | Iron sucrose: the oldest iron therapy becomes new. | 2002 | Am. J. Kidney Dis. | pmid:12460028 |
| Bailie GR et al. | Parenteral iron use in the management of anemia in end-stage renal disease patients. | 2000 | Am. J. Kidney Dis. | pmid:10620537 |
| Van Wyck DB et al. | Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. | 2000 | Am. J. Kidney Dis. | pmid:10873877 |
| Fishbane S | Safety issues with iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:12666081 |
| Geisser P | Reactivity of iron compounds. | 2003 | Am. J. Kidney Dis. | pmid:14582056 |
| Danielson BG and Beshara S | Pharmacokinetics and utilization of iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:14582057 |
| McMahon LP et al. | Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis. | 2004 | Am. J. Kidney Dis. | pmid:15332224 |
| Goldstein SL et al. | Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial. | 2013 | Am. J. Kidney Dis. | pmid:23245582 |
| Silverberg DS et al. | Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. | 1996 | Am. J. Kidney Dis. | pmid:8659499 |
| Charytan C et al. | Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. | 2001 | Am. J. Kidney Dis. | pmid:11157370 |
| Duffy CI | Iron sucrose or ferric gluconate? | 2001 | Am. J. Kidney Dis. | pmid:11728988 |
| Freburger JK et al. | Changing patterns of anemia management in US hemodialysis patients. | 2012 | Am. J. Med. | pmid:22938926 |
| Rostoker G et al. | Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. | 2012 | Am. J. Med. | pmid:22998881 |
| Barton Pai A et al. | Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose. | 2006 | Am. J. Nephrol. | pmid:16809897 |
| Kamanna VS et al. | Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. | 2012 | Am. J. Nephrol. | pmid:22212390 |
| Ichii H et al. | Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. | 2012 | Am. J. Nephrol. | pmid:22722756 |
| Takeda Y et al. | Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. | 2011 | Am. J. Nephrol. | pmid:21502756 |
| Taccone-Gallucci M et al. | Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis. | 1987 | Am. J. Nephrol. | pmid:3578371 |
| Malindretos P et al. | Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. | 2007 | Am. J. Nephrol. | pmid:17804904 |
| Breymann C et al. | Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11262469 |
| Bayoumeu F et al. | Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. | 2002 | Am. J. Obstet. Gynecol. | pmid:11904617 |
| Douard V et al. | Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. | 2013 | Am. J. Physiol. Endocrinol. Metab. | pmid:23571713 |
| Bitsi S et al. | Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:26670484 |
| Stachowska-Pietka J et al. | Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach. | 2012 | Am. J. Physiol. Renal Physiol. | pmid:22301624 |
| Johnson AC et al. | Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury. | 2010 | Am. J. Physiol. Renal Physiol. | pmid:20504881 |
| Agarwal R | On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. | 2005 | Am. J. Physiol. Renal Physiol. | pmid:15467003 |
| Froessler B and Papendorf D | Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management. | 2010 | Anaesth Intensive Care | pmid:20865896 |
| Marsh CA | An enzymatic determination of D-glucaric acid by conversion to pyruvate. | 1985 | Anal. Biochem. | pmid:3893213 |
| Previs SF et al. | Use of [6,6-2H2]glucose and of low-enrichment [U-13C6]-glucose for sequential or simultaneous measurements of glucose turnover by gas chromatography-mass spectrometry. | 1994 | Anal. Biochem. | pmid:8053553 |
| Blumenthal HJ et al. | Specific enzymatic assay for D-glucarate in human serum. | 1990 | Anal. Biochem. | pmid:2187374 |
| Ryzewski CN and Malejka-Giganti D | A novel assay of glucuronidation of C- and N-hydroxylated metabolites of the carcinogen N-2-fluorenylacetamide. | 1983 | Anal. Biochem. | pmid:6408946 |
| Nakajima M et al. | A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity. | 1986 | Anal. Biochem. | pmid:3766958 |
| Cuenca J et al. | Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. | 2008 | Anesthesiology | pmid:18580186 |
| Bayoumeu F et al. | [Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation]. | 2002 | Ann Fr Anesth Reanim | pmid:11878118 |
| Dolara P et al. | Variations of some parameters of enzyme induction in chemical workers. | 1982 | Ann Occup Hyg | pmid:6124202 |
| Dolara P et al. | Enzyme induction in humans exposed to styrene. | 1983 | Ann Occup Hyg | pmid:6614729 |
| Siest G et al. | [Biological tests as indirect indicators of the activity of drug metabolizing enzymes. Use of glucaric acid and gamma-glutamyltransferase]. | 1977 | Ann. Biol. Clin. (Paris) | pmid:28055 |
| Brewster MA | Biomarkers of xenobiotic exposures. | 1988 Jul-Aug | Ann. Clin. Lab. Sci. | pmid:3044268 |
| Street JC and Chadwick RW | Ascorbic acid requirements and metabolism in relation to organochlorine pesticides. | 1975 | Ann. N. Y. Acad. Sci. | pmid:54013 |
| Addyman R et al. | Urinary glucaric acid excretion in rheumatoid arthritis: influence of disease activity and disease modifying drugs. | 1996 | Ann. Rheum. Dis. | pmid:8774168 |